DHR - Danaher Corporation

Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C.. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 3 platforms are Life Sciences, Diagnostics, and Environmental & Applied Solutions.

52W High

$278.43

52W Low

$170.73

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.78

Valuation

Fair

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

42.60

Forward P/E (<15 better)

23.36

EV/EBITDA (<8 favorable)

23.35

EV/Revenue (<3 favorable)

6.57

P/S (TTM) (<3 favorable)

5.97

P/B (<3 favorable)

2.74

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

11.05%

Institutions (25–75% balanced)

82.73%

Shares Outstanding

716,052,000

Float

637,128,000

Dividend Yield (2–6% sweet spot)

0.01%

Ex‑Dividend Date

2025-06-27

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

24,013,001,000

Gross Profit (TTM)

14,340,000,000

EPS (TTM)

4.70

Profit Margin (>10% good)

0.14%

Operating Margin (TTM) (higher better)

0.20%

ROE (TTM) (>15% strong)

0.07%

EPS YoY (Quarterly) (>10% good)

-0.37

Revenue YoY (Quarterly) (>8% good)

0.03

Momentum

Bearish momentum

Value

-3.4301

-2.7095

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025